Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Open Access
- 1 May 2009
- journal article
- review article
- Published by Informa UK Limited in Vascular Health and Risk Management
- Vol. 5 (1), 411-427
- https://doi.org/10.2147/VHRM.S4235
Abstract
Peer reviewed article authored by (Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia). Read article or submit your manuscript for publishing.Keywords
This publication has 102 references indexed in Scilit:
- Diuretic and Enhanced Sodium Restriction Results in Improved Antiproteinuric Response to RAS Blocking AgentsJournal of the American Society of Nephrology, 2005
- Fixed-Dose Combinations in the Management of HypertensionAmerican Journal of Cardiovascular Drugs, 2005
- Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril StudyHypertension, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Effect of Low-Dose Perindopril/Indapamide on Albuminuria in DiabetesHypertension, 2003
- Improvement in Blood Pressure, Arterial Stiffness and Wave Reflections With a Very-Low-Dose Perindopril/Indapamide Combination in Hypertensive PatientHypertension, 2001
- Low-dose drug combination therapy: An alternative first-line approach to hypertension treatmentAmerican Heart Journal, 1995
- Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasThe Lancet, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Captopril enhances insulin responsiveness of forearm muscle tissue in non‐insulin‐dependent diabetes mellitusEuropean Journal of Clinical Investigation, 1987